PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Cannabis » ChineseInvestors.com, Inc. Announces 3Q Financial Results, Posts Nearly 100% YoY Increase, Expects Hemp Products to Generate Substantial Revenues in 2018

ChineseInvestors.com, Inc. Announces 3Q Financial Results, Posts Nearly 100% YoY Increase, Expects Hemp Products to Generate Substantial Revenues in 2018

by PublicWire
April 26, 2019
in Cannabis
Reading Time: 4 mins read
0

PR Newswire, CIIX

SAN GABRIEL, California, April 24, 2017

SAN GABRIEL, California, April 24, 2017 /PRNewswire/ —

ChineseInvestors.com, Inc. (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today provides an update on its financial and business achievements for the third quarter of 2017, as well as its outlook for the remainder of the current fiscal year and 2018.

Financial Highlights:

  • Filed form 10Q with the U.S. Securities and Exchange Commission (SEC) reflecting significantly higher revenues for the three- and nine-month periods ended February 28, 2017, as compared to the same periods of fiscal 2016. Operating revenues increased 95% and 109%, respectively.
  • Revenues from the investor relations business continued to grow in the third quarter, accounting for approximately 60% of total revenues.

Business Highlights:

  • Completed a $5 million private placement with proceeds to be allocated toward the development and branding of hemp-based health production line and retail sales operations; Shanghai & United States office expansions and infrastructure development, among other things.
  • Officially established and registered CBD Biotechnology Co. Ltd. (“XiBiDi Biotechnology Co. Ltd.”), a wholly owned foreign entity of CIIX, in the Pudong Free-Trade Area in Shanghai.
  • Officially launched Chinese language online store ChineseCBDoil.com operated by CBD Biotechnology Co. Ltd., offering hemp-based health products to the Chinese community.
  • We have begun a private placement of a new series of our preferred stock offered only to Canadian investors.

In recognition of the unprecedented opportunities in the legal hemp industry, CIIX has expanded its business to capitalize on the growing demand for hemp-based health products via online and retail sales. As part of its expansion, the Company will focus on the operation of its new wholly owned foreign entity, CBD Biotechnology Co. Ltd. In addition earlier this month, the company established ChineseHempoil.com, Inc. and Hemp Logic, Inc. dba Hempstatic, both Delaware corporations, as subsidiaries of CIIX. Chinesehempoil.com, Inc. and Hemp Logic, Inc. are responsible for the development and operation of the online and retail sales of hemp-based health products in the United States. CIIX will soon open its first retail store in the predominantly Chinese community of San Gabriel, California, which is also the location of the Company’s headquarters. CIIX also maintains its commitment to continue to grow its membership subscriptions and investor relations business.

According to our chief executive officer, Warren Wang, “Development of a line of our hemp-based health products, for the most part, is complete and preparation of related websites, retail channels and marketing campaigns are entering the final stages as well. The Company’s hemp-based health products are expected to be available in the North American markets in the coming weeks. CIIX will continue to develop various hemp-based products for distribution and sale all over the world in hopes of helping people to improve their overall health, particularly in the Chinese community. I am grateful for to the investors who have supported our ongoing development plans and look forward to a prosperous year ahead.”

Looking forward, Wang states, “The blueprint of our Company’s corporate business strategy has changed as we are entering the legal hemp industry and because of this, our revenues this quarter did not exceed that of the previous quarter. However, revenues for the nine-month period increased by more than 100%. We believe our plan to market and sell hemp-based health products in the United States and China will generate substantial revenues for CIIX in FY2018. Our overall goal in 2018 is for CIIX to achieve annual revenue growth rate of more than 100%, while cutting costs and achieving profitability.”

About ChineseInvestors.com (OTCQB: CIIX)

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products via its new websites.

For more information visit https://www.ChineseInvestors.com

Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom

Follow us on Twitter for real-time Company updates: https://twitter.com/ChineseFNEnglsh

Like us on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom and https://www.facebook.com/Chineseinvestors.com.english

Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Tags: 3QCBDCBD Biotechnology Co. LtdChineseCBDoil.comChineseInvestors.comCIIXFinancial Resultshemp-based healthRevenues
Previous Post

Indoor Harvest Corp Signs Definitive Agreement to Acquire Alamo CBD

Next Post

Jerry Heller’s Company Merges With Everlert, Inc. to Create Private Equity Fund for Entertainment Ventures

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Photo by GRAS GRÜN on Unsplash
Cannabis

Zenabis returned $1.9 million worth of pot to Sundial over bad quality and visible molds

August 22, 2019
0
Photo by Rick Proctor on Unsplash
Cannabis

Tilray to start exporting medicinal pot to Germany

August 21, 2019
0
Photo by Esteban Lopez on Unsplash
Cannabis

CannTrust stocks fell another 5% after weed distributor returned millions worth of pot

August 20, 2019
0
Photo by Roberto Valdivia on Unsplash
Cannabis

Cannabis stocks fell as possible recession brews

August 14, 2019
0
Cannabis

Aurora Cannabis hovers trade flat amid strong market

August 13, 2019
0
Photo by Get Budding on Unsplash
Cannabis

Health inspectors flagged CannTrust’s non-compliance again, sending stocks down by 26%

August 12, 2019
0
Next Post

Jerry Heller's Company Merges With Everlert, Inc. to Create Private Equity Fund for Entertainment Ventures

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.